Cited by 83Characterization and Applications of Magnetic NanoparticlesNanoparticle-Based Drug DeliveryChronic Obstructive Pulmonary Disease (COPD) Research

MR imaging and targeting of a specific alveolar macrophage subpopulation in LPS-induced COPD animal model using antibody-conjugated magnetic nanoparticles

Open access
Al Faraj, Achraf, Sultana Shaik, Asma, Afzal, Sibtain, Al Sayed, Baraa, Halwani, Rabih·2014·International Journal of Nanomedicine

Abstract

PURPOSE: Targeting and noninvasive imaging of a specific alveolar macrophage subpopulation in the lung has revealed the importance for early and better diagnosis and therapy of chronic obstructive pulmonary disease (COPD). In this study, the in vivo effect of pulmonary administration of iron oxide nanoparticles on the polarization profile of macrophages was assessed, and a noninvasive free-breathing magnetic resonance imaging (MRI) protocol coupled with the use of biocompatible antibody-conjugated superparamagnetic iron oxide (SPIO) nanoparticles was developed to enable specific targeting and imaging of a particular macrophage subpopulation in lipopolysaccharide-induced COPD mice model. MATERIALS AND METHODS: Enzyme-linked immunosorbent assay, Real-time polymerase chain reaction, and flow cytometry analysis were performed to assess the biocompatibility of PEGylated dextran-coated SPIO nanoparticles. Specific biomarkers for M1 and M2 macrophages subsets were selected for conjugation with magnetic nanoparticles. MRI protocol using ultra-short echo time sequence was optimized to enable simultaneous detection of inflammation progress in the lung and detection of macrophages subsets. Flow cytometry and immunohistochemistry analysis were finally performed to confirm MRI readouts and to characterize the polarization profile of targeted macrophages. RESULTS: The tested SPIO nanoparticles, under the current experimental conditions, were found to be biocompatible for lung administration in preclinical settings. Cluster of differentiation (CD)86- and CD206-conjugated magnetic nanoparticles enabled successful noninvasive detection of M1 and M2 macrophage subpopulations, respectively, and were found to co-localize with inflammatory regions induced by lipopolysaccharide challenge. No variation in the polarization profile of targeted macrophages was observed, even though a continuum switch in their polarization might occur. However, further confirmatory studies are required to conclusively establish this observation. CONCLUSION: Coupling of magnetic iron oxide nanoparticles with a specific antibody targeted to a particular macrophage subpopulation could offer a promising strategy for an early and better diagnosis of pulmonary inflammatory diseases using noninvasive MRI.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/ijn.s59394

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Noninvasive nanoparticle-mediated high-contrast imaging methods may be promising for diagnosis of pulmonary inflammation.

    “Such noninvasive nanoparticle-mediated high-contrast imaging methods may be promising for the diagnosis of pulmonary inflammation.189”
  • Anti-CD86 and anti-CD206 antibody-conjugated SPIO NPs demonstrated specific adherence to proinflammatory M1 and resolutive M2 macrophage subpopulations in COPD mouse models.

    “Anti-CD86 and anti-CD206 antibody-conjugated SPIO NPs were instilled in COPD mouse models via the intrapulmonary route, and the NPs demonstrated specific adherence to the proinflammatory (M1) and resolutive (M2) macrophage subpopulations.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Al Faraj, A., Sultana Shaik, A., Afzal, S., Al Sayed, B., & Halwani, R.
Affiliations
King Saud University (SA)
Venue
International Journal of Nanomedicine
Published
2014-03
Volume
9
Pages
1491
ISSN
  • 1176-9114 (ISSN-L)
  • 1178-2013
OpenAlex
W2088047310
Cited by
83
References
43
Citations by year
2026: 6 · 2025: 8 · 2024: 4 · 2023: 6 · 2022: 8 · 2021: 8 · 2020: 7 · 2019: 6 · 2018: 3 · 2017: 6 · 2016: 5 · 2015: 10 · 2014: 6
FWCI
4.67
Type
journal article
Language
en
Open access
Locations
  • International Journal of Nanomedicine (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Funders
  • King Saud University
  • Université de Lyon
  • National Plan for Science, Technology and Innovation
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › Characterization and Applications of Magnetic Nanoparticles
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Keywords
chronic obstructive pulmonary disease, alveolar macrophages, macrophage polarization, M1/M2 macrophages, superparamagnetic iron oxide nanoparticles, antibody-conjugated nanoparticles, lipopolysaccharide-induced lung inflammation, CD86, CD206, nanoparticle biocompatibility, ultrashort echo time MRI
MeSH terms
Animals, Antibodies, Contrast Media, Dextrans, Female, Lipopolysaccharides, Macrophages, Magnetic Resonance Imaging, Mice, Inbred BALB C, Pulmonary Alveoli, Sensitivity and Specificity, Reproducibility of Results, Pulmonary Disease, Chronic Obstructive, Mice, Magnetite Nanoparticles, Cell Tracking

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review